Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis

…, RP Sundel, D Milojevic, MG Punaro… - Arthritis & …, 2012 - Wiley Online Library
Objective To determine whether aggressive treatment initiated early in the course of rheumatoid
factor (RF)–positive or RF‐negative polyarticular juvenile idiopathic arthritis (JIA) can …

[HTML][HTML] Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases

…, N Pan, P Pillet, DGP Piotto, MG Punaro… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Undifferentiated systemic autoinflammatory diseases (USAIDs) present
diagnostic and therapeutic challenges. Chronic interferon (IFN) signaling and cytokine …

Randomized, double‐blind, placebo‐controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis

…, Y Kimura, LF Imundo, MG Punaro… - Arthritis & …, 2014 - Wiley Online Library
Objective To assess the efficacy and safety of rilonacept, an interleukin‐1 inhibitor, in a
randomized, double‐blind, placebo‐controlled trial. Methods An initial 4‐week double‐blind …

[BOOK][B] Paediatric nephrology

L Rees, D Bockenhauer, NJA Webb, MG Punaro - 2019 - books.google.com
The Oxford Specialist Handbook of Paediatric Nephrology helps the reader understand and
manage all conditions affecting the kidney in childhood. This concise yet comprehensive …

The lupus family registry and repository

…, MC Ballesteros, MG Punaro… - …, 2011 - academic.oup.com
The Lupus Family Registry and Repository (LFRR) was established with the goal of
assembling and distributing materials and data from families with one or more living members …

Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement …

…, RP Sundel, DS Milojevic, MG Punaro… - The Journal of …, 2014 - jrheum.org
Objective. To determine the elapsed time while receiving aggressive therapy to the first
observation of clinically inactive disease (CID), total duration of CID and potential predictors of …

[HTML][HTML] Age and fecal microbial strain-specific differences in patients with spondyloarthritis

…, MI Danila, CH Spencer, MG Punaro… - Arthritis research & …, 2018 - Springer
Background Prior studies have demonstrated abnormalities in the composition of the
gastrointestinal microbiota in pediatric and adult patients with spondyloarthritis (SpA). In particular, …

Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists

…, GC Higgins, KA Haines, MG Punaro… - The Journal of …, 2010 - jrheum.org
Objective. We surveyed pediatric rheumatologists (PR) in North America to learn how they
treat pediatric localized scleroderma (LS), a disease associated with significant morbidity for …

Race, income, and disease outcomes in juvenile dermatomyositis

…, KM O'Neil, K Onel, S Prahalad, MG Punaro… - The Journal of …, 2017 - Elsevier
Objective To determine the relationships among race, income, and disease outcomes in
children with juvenile dermatomyositis (JDM). Study design Data from 438 subjects with JDM …

Association of Anti–3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Autoantibodies With DRB1* 07: 01 and Severe Myositis in Juvenile Myositis Patients

…, MD Perez, DA Person, MG Punaro… - Arthritis care & …, 2017 - Wiley Online Library
Objective Autoantibodies recognizing 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase (HMGCR)
are associated with statin exposure, the HLA allele DRB1*11:01, and necrotizing …